
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades for Rambus, WEC Energy, Dynatrace, and Teva Pharma.
InvestingPro subscribers got this news before anyone else. Start your 7-day trial to get on board.
Rambus (NASDAQ:RMBS) shares surged more than 9% yesterday after Jefferies upgraded the company to Buy from Hold and raised its price target to $65.00 from $45.00, as reported in real time on InvestingPro.
The upgrade followed recent meetings with management and increased confidence in the company’s positioning. According to Jefferies, the company is well positioned for not only leading buffer chip share in ramping DDR5 but also for a meaningful share in the significant adjacent growth opportunities of companion chips and CXL.
Earlier this month, the company reported its Q1 earnings, significantly missing the Street estimates.
Mizuho Securities upgraded WEC Energy (NYSE:WEC) to Buy from Neutral with a price target of $98.00.
According to the firm, regulatory concerns that resulted in a stock underperformance over the past two months are overblown given WEC largely resolved its WI filings earlier this year, covering the WI utilities through 2024. Furthermore, on the IL side, the firm noted that the staff testimony published earlier this month appears constructive.
BTIG upgraded Dynatrace (NYSE:DT) to Buy from Neutral with a price target of $57.00 following the Q4 beat on Wednesday, highlighted by upside on all key metrics.
According to BTIG, growth appears to be stabilizing despite macro headwinds and ongoing customer cloud optimization initiatives. Furthermore, the firm noted that commentary on new products, namely application security and log monitoring, was encouraging.
Evercore ISI upgraded Teva Pharma (NYSE:TEVA) to Outperform from In Line following the company's reported Q1 results last week, with revenue coming in better than expected, while EPS missing the estimates.
In fast-moving markets, every second counts - and InvestingPro subscribers are always one step ahead with lightning-quick updates.
Start your free 7-day trial now.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.